• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用β-环糊精增溶药物:实验数据与建模。

Solubilization of drugs using beta-cyclodextrin: Experimental data and modeling.

机构信息

Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Ann Pharm Fr. 2024 Jun;82(4):663-672. doi: 10.1016/j.pharma.2024.02.003. Epub 2024 Feb 8.

DOI:10.1016/j.pharma.2024.02.003
PMID:38340807
Abstract

Many drug candidates fail to complete the entire drug development process because of poor physicochemical properties. Solubility is an important physicochemical property which plays a vital role in various stages of drug discovery and development. Several methods have been proposed to enhance the solubility of drugs, and complex formation with cyclodextrins is among them. Beta-cyclodextrin (βCD) is a common excipient for solubilization of drugs. The aim of this study is to develop the mechanistic QSPR models to predict the solubility enhancement of a drug in the presence of βCD. In this study, the solubility enhancement of some drugs in the presence of 10mM βCD at 25°C was experimentally determined or collected from the literature. Two different models to predict the solubilization by βCD were developed by binary logistic regression using structural properties of drugs with more than 80% accuracy. Polar surface area and excess molar refraction are the main parameters for estimating solubilization by βCD. Moreover, other descriptors related to hydrophobicity and the capability of hydrogen bonding formation of molecules could improve the accuracy of the established models.

摘要

由于较差的物理化学性质,许多候选药物无法完成整个药物开发过程。溶解度是一个重要的物理化学性质,在药物发现和开发的各个阶段都起着至关重要的作用。已经提出了几种提高药物溶解度的方法,其中包括与环糊精形成复合物。β-环糊精(βCD)是增溶药物的常用赋形剂。本研究旨在建立机制 QSPR 模型,以预测药物在βCD 存在下的溶解度增强。在这项研究中,通过实验测定或从文献中收集了一些药物在 25°C 下存在 10mMβCD 时的溶解度增强。使用药物的结构性质,通过二元逻辑回归建立了两种不同的模型来预测βCD 的增溶作用,准确率超过 80%。极性表面积和过量摩尔折射是估计βCD 增溶作用的主要参数。此外,与分子疏水性和氢键形成能力相关的其他描述符可以提高所建立模型的准确性。

相似文献

1
Solubilization of drugs using beta-cyclodextrin: Experimental data and modeling.利用β-环糊精增溶药物:实验数据与建模。
Ann Pharm Fr. 2024 Jun;82(4):663-672. doi: 10.1016/j.pharma.2024.02.003. Epub 2024 Feb 8.
2
Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.溶液和固态中扎来普隆与环糊精和亲水性聚合物的络合的比较分析。
J Pharm Biomed Anal. 2012 Dec;71:35-44. doi: 10.1016/j.jpba.2012.07.027. Epub 2012 Jul 31.
3
β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs.用于增溶难溶性药物的β-环糊精-葡聚糖聚合物
Int J Pharm. 2014 Jul 1;468(1-2):258-63. doi: 10.1016/j.ijpharm.2014.04.029. Epub 2014 Apr 16.
4
Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.依折麦布与羟丙基-β-环糊精及亲水性辅料制剂的水溶解度改善及抗高胆固醇活性
AAPS PharmSciTech. 2016 Apr;17(2):272-83. doi: 10.1208/s12249-015-0344-7. Epub 2015 Jun 16.
5
Carboxymethyl and hydrazide functionalized β-cyclodextrin derivatives: a systematic investigation of complexation behaviours with the model hydrophobic drug dexamethasone.羧甲基和酰肼功能化的β-环糊精衍生物:与模型疏水药物地塞米松络合行为的系统研究
Int J Pharm. 2014 Sep 10;472(1-2):315-26. doi: 10.1016/j.ijpharm.2014.06.046. Epub 2014 Jun 27.
6
Development of machine learning models of β-cyclodextrin and sulfobutylether-β-cyclodextrin complexation free energies.β-环糊精和磺丁基醚-β-环糊精包合自由能的机器学习模型的开发。
Int J Pharm. 2011 Oct 14;418(2):207-16. doi: 10.1016/j.ijpharm.2011.03.065. Epub 2011 Apr 8.
7
Determination of excipient based solubility increases using the CheqSol method.利用 CheqSol 法测定辅料增溶作用。
Int J Pharm. 2014 Apr 25;465(1-2):202-9. doi: 10.1016/j.ijpharm.2014.02.007. Epub 2014 Feb 7.
8
Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.分析三氯生与β-环糊精及其水溶性聚合物衍生物的包合物。
J Pharm Biomed Anal. 2011 Apr 5;54(5):1030-9. doi: 10.1016/j.jpba.2010.12.009. Epub 2010 Dec 16.
9
Development of improved empirical models for estimating the binding constant of a beta-cyclodextrin inclusion complex.用于估算β-环糊精包合物结合常数的改进经验模型的开发。
Pharm Res. 2009 Jan;26(1):161-71. doi: 10.1007/s11095-008-9733-x. Epub 2008 Oct 9.
10
Modeling the effect of selected cyclodextrins on nifedipine solubility.模拟选定环糊精对硝苯地平溶解度的影响。
Curr Drug Discov Technol. 2011 Jun;8(2):146-54. doi: 10.2174/157016311795563884.

引用本文的文献

1
Computational approaches for toxicology and Pharmacokinetic properties prediction.毒理学和药代动力学性质预测的计算方法。
J Pharmacokinet Pharmacodyn. 2025 Sep 4;52(5):51. doi: 10.1007/s10928-025-09999-y.